FOUNDAYO

ORFORGLIPRON · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FOUNDAYO, covering 2026-04-01 to 2026-08-04. Get the full timeline:

Most recent: FDA Approved: FOUNDAYO — Supplemental Application (Eli Lilly and Company)